Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 38 for “"percutaneous coronary intervention"”.
-
Clinical and angiographic outcome following percutaneous coronary intervention
… of linking chapters that follow the evolution of percutaneous intervention from conventional balloon angioplasty in the early to mid 1990s to stent implantation which has now become standard practice. It describes contributions to the extension of clinical situations in which percutaneous …
-
Percutaneous coronary intervention, repatriation and unplanned readmissions: Characteristics of percutaneous coronary intervention patients who experience an unplanned readmission after repatriation from a tertiary hospital
… into transportation of acutely unwell or post interventional cardiac patients in the aeromedical environment. In the New Zealand context there are no consistent guidelines between the various aeromedical services for the transportation of cardiac patients in air ambulances. OBJECTIVE The …
-
Clinical outcome and Predictive factors of Coronary aneurysm after Percutaneous Coronary Intervention
Coronary artery aneurysms (CAAs) defined as angiographic luminal dilatation (50% larger than the adjacent reference vessel) at the site of stent implantation are rare and the reported incidence varies from 0.3% to 6%(Aoki et al., 2008). A new term, peri-stent contrast staining (PSS) was defined as …
-
Comparison of Aspiration Thrombectomy with Glycoprotein IIb/IIIa Inhibitor versus Aspiration Thrombectomy Alone in Primary Percutaneous Coronary Intervention
목적 : 흡입 혈전제거술과 당단백질 IIb/IIIa 수용체 차단제는 ST분절 상승을 동반한 급성심근경색 환자의 일차적 중재시술에 있어서 허혈성 합병증을 감소시키고 임상결과를 개선시키는 것으로 알려져 있다. 그러나 흡입 혈전제거술만 시행한 것에 비해 당단백질 IIb/IIIa 수용체 차단제의 추가적 사용이 임상 결과에 미치는 영향에 대해서는 잘 알려진 바가 없다. 이 연구의 목적은 ST분절 상승을 동반한 급성심근경색 환자의 일차적 중재시술에 있어서 흡입 혈전제거술만 시행한 군과 추가적인 당단백질 IIb/IIIa 수용체 차단제를 사용한 …
-
Clinical and Angiographic Predictive Factor for the Development of No-reflow/Slow flow Phenomenon during Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
… use of distal protective device during primary percutaneous coronary intervention(PCI) for AMI reduce no-reflow/slow flow phenomenon in some patients, but not all cases. The identification of high risk group for development of no-reflow/slow flow phenomenon is important. We assessed the clinical …
-
Impact of Transradial Approach in Patients with High Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Abciximab on In-Hospital Clinical Outcomes and Bleeding Complications
… numbers of studies suggesting that transradial coronary intervention (TRI) is associated with better clinical outcomes by reducing bleeding and vascular complications when compared with transfemoral coronary intervention (TFI). The benefit of TRI might be enlarged in patients at high risk of …
-
A cross-sectional study of ECG patterns and outcomes of patients thrombolysed for ST-elevation myocardial infarction at a district, public Cape Town hospital
… for STEMI at a public hospital without primary percutaneous coronary intervention capability as well as associated ECG changes. Materials and methods A retrospective, cross- sectional study was conducted at an urban, public emergency centre in Cape Town, South Africa that did not have direct …
-
Retrieving a Stent Navigating Deep Complications
… describe a case of an infrequent complication of percutaneous coronary intervention in a patient with acute ST-segment elevation myocardial infarction and discuss considerations for its prevention, recognition, and treatment. KEY STEPS Diagnostic coronary angiography confirmed an acute total …
-
Papildomas adenozino vaidmuo mažinant infarkto dydį ir išsaugant kairiojo skilvelio funkciją pacientams, sergantiems ūminiu miokardo infarktu /
… an adjunct to conventional reperfusion therapy (percutaneous coronary intervention, i.e. PCI), role in reducing the infarct size and preserving the left ventricular function in patients with acute myocardial infarction. During the study we examined patients with the left ventricular anterior wall …
-
The American Heart Association 2005 Emergency Cardiovascular Care Guidelines Impact on Myocardial Infarction Mortality in Nevada Hospitals
… the impact of the recommend guideline that percutaneous coronary intervention (PCI) be implemented within 90 minutes from emergency room arrival to the PCI (door-to-balloon). The PCI guideline is expected to decrease AMI mortality. AMI mortality is adjusted for comorbidities and other …
-
Quality of life and ethics-patients with ischemic heart disease
… after acute myocardial infarction (AMI) (n=296), coronary artery bypass grafting (CABG) (n=99) and percutaneous coronary intervention (PCI) (n=18) patients completed a questionnaire for self-assessment of quality of life (QoL) during the period 1989?1991. Patients differed from age- and …
-
Genotype- versus phenotype-directed personalization of antiplatelet treatment in Koreans with coronary artery disease undergoing coronary stenting
… (HOPR). Sixty-five patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes were randomly assigned to genotype- or phenotype-directed treatment. All patients were screened for the CYP2C19 *2, *3, or *17 alleles by using Verigene CLO assay …
-
Prehospital Delay, Procrastination and Personality in Patients with Acute Coronary Syndrome
Coronary heart disease alone caused one out of every six deaths in the United States in 2009. Individuals who experience signs and symptoms of acute coronary syndrome (ACS) often delay seeking treatment. Compared to patients who arrive within two hours of symptom onset, those with prolonged …
-
Correlation Between Serum Bilirubin Level and Coronary Microvascular Integrity in Diabetic Patients
… role in suppressing atherosclerosis and coronary artery disease. There has not been comparative studies for the relation of bilirubin level and coronary microvascular function in diabetes. This study investigates whether bilirubin can preserve coronary microvascular integrity in diabetes, …
-
Crosstalk Signaling Between cAMP and Calcium on the Leading Edge of Migrating Human Arterial Vascular Smooth Muscle Cells
… Currently, vessel stenosis is reversed by percutaneous coronary intervention (PCI) and the placement of drug eluting stents (DES) coated with pan-cellular anti-proliferative agents. Although these approaches are effective, in-stent restenosis and thrombosis remain problematic, in part due …
-
Clinical, Invasive and Non-Invasive Factors Affecting Outcomes in Patients with Acute Coronary Syndromes
In this thesis, factors affecting outcomes after percutaneous coronary intervention (PCI), the most common interventional procedure performed, were examined. To constrain procedural costs, selective criteria for drug-eluting stents (DES), which reduce restenosis, were developed in 2003 at Liverpool …
-
Bleeding Risk Following Percutaneous Intervention in Patients with Diabetes Prescribed Dual Anti Platelet Therapy
… drug eluting stent (DES) implant at the time of percutaneous coronary intervention (PCI). DES stent implantation necessitates prolonged dual anti-platelet therapy (DAPT). While DAPT reduces the risk of ischemic events post-PCI, it also increases the risk for bleeding. Whether long-term rates of …
-
Comparison of Patient-Reported Angina with Provider Assigned Canadian Cardiovascular Society Angina Class Before and After Revascularization
… from over 160 international sites to either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), CCS was reported by physicians and the SAQ was completed by patients prior to randomization and 1 year later. SAQ angina frequency (SAQ AF) scores were considered to …
Page 1 of 2